Implantable cardioverter/defibrillator therapy in arrhythmogenic right ventricular cardiomyopathy: Single-center experience of long-term follow-up and complications in 60 patients

Arrhythmogenic right ventricular cardiomyopathy (ARVC) is a major cause of ventricular tachycardia (VT) and cardiac arrest in young patients. We hypothesized that treatment with implantable cardioverter/defibrillators (ICDs) is safe and improves the long-term prognosis of ARVC patients at high risk...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Circulation (New York, N.Y.) N.Y.), 2004-03, Vol.109 (12), p.1503-1508
Hauptverfasser:	WICHTER, Thomas, PAUL, Matthias, SCHELD, Hans H, BREITHARDT, Günter, BÖCKER, Dirk, WOLLMANN, Christian, ACIL, Tayfun, GERDES, Petra, ASHRAF, Obaidullah, TJAN, Tonny D. T, SOEPARWATA, Rasijd, BLOCK, Michael, BORGGREFE, Martin
Format:	Artikel
Sprache:	eng
Schlagworte:	Adolescent Adult Aged Anti-Arrhythmia Agents - therapeutic use Arrhythmogenic Right Ventricular Dysplasia - complications Arrhythmogenic Right Ventricular Dysplasia - drug therapy Arrhythmogenic Right Ventricular Dysplasia - therapy Biological and medical sciences Blood and lymphatic vessels Cardiology. Vascular system Combined Modality Therapy Defibrillators, Implantable - adverse effects Diseases of the peripheral vessels. Diseases of the vena cava. Miscellaneous Electric Countershock Electrocardiography Equipment Failure Female Fibrosis Humans Intraoperative Care Male Medical sciences Middle Aged Proportional Hazards Models Prospective Studies Syndrome Terminology as Topic Treatment Outcome Ventricular Fibrillation - etiology Ventricular Fibrillation - prevention & control
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!